HealthDay (8/29, Reinberg) reports, “Labor shortages at Teva Pharmaceuticals have made Adderall [amphetamine/dextroamphetamine],” a treatment of attention-deficit/hyperactivity disorder (AD/HD), “hard to find in some drugstores,” even though the FDA has “noted that there’s no overall shortage of” medications to treat AD/HD. Just “Teva is reporting supply problems, FDA spokeswoman Cherie Duvall-Jones told NBC News.”
Related Links:
— “ADHD Drug Adderall in Short Supply “Steven Reinberg, HealthDay, August 29, 2022